Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Novo Nordisk withdraws FDA application to expand use of weight loss drug

The Danish pharmaceutical company said it will resubmit its application in 2025 to have Wegovy approved for use in heart failure patients.

ACA premiums expected to rise 7% in 2025, report finds

A survey from KFF survey found the spike in cost will be mitigated by subsidies. However, the number of uninsured Americans could rise.

artificial intelligence AI money brain dollar

Radiology AI triage solution earns separate, additional Medicare hospital payment

The Centers for Medicare & Medicaid Services revealed the news under the 2025 Inpatient Prospective Payment System rule released on Aug. 1

cleveland clinic settles for failing to disclose research funding

Appeals court notches radiology another win in fight to fix No Surprises Act

The Radiology Business Management Association on Tuesday praised the ruling, calling it a “significant victory for patients and providers.” 

doctor examines patient data on their tablet

FDA sees potential in new PET imaging agent for cardiac amyloidosis

Early evidence suggests a new PET imaging agent from California-based Attralus can help evaluate all varieties of systemic cardiac amyloidosis. It has now been granted the FDA's breakthrough therapy designation. 

Bharath Krishnamurthy, a director of health policy and analytics at the American Hospital Association (AHA), factors that are leading to instability the U.S. healthcare system. #AHA #AmericanHospitalAssociation #CMS #Healthcare

Challenges to the financial stability of the American healthcare system

Bharath Krishnamurthy, director of health policy and analytics, American Hospital Association, explains factors leading to the economic instability of the U.S. healthcare system. 

Thumbnail

FDA denies pharma firm’s initial application for new kidney cancer imaging agent

Telix Pharmaceuticals Ltd. announced the news on July 31, with the decision applying to its TLX250-CDx investigational agent for clear cell renal cell carcinoma (brand name Zircaix). 

The Texas State Capital building in Austin where 140 scope creep bills were defeated in 2024 by the Texas medical Association.

Texas legislature held ground in face of scope of practice expansion bills

The AMA applauded the Texas Medical Association for defeating dozens of scope of practice creep bills in the Texas legislature this year.